Prevalence of JC Polyomavirus Among Rheumatoid Arthritis and Systemic Lupus Erythematosus Patients and Its Correlation with Vitamin D Levels

Overview

Journal Iran J Microbiol

Publisher Tehran University of Medical Sciences

Specialty Infectious Diseases

Date 2024 Nov 13

PMID 39534291

Authors

Golnaz Irani Mokhtari

Azarakhsh Azaran

Elham Rajahi

Saeed Hesam

Azam Dehghani Ghahfarokhi

Manoochehr Makvandi

Affiliations

Soon will be listed here.

Abstract

Background And Objectives: Vitamin D deficiency in viral infection associated with autoimmune diseases is well documented. This study assessed the prevalence of JC virus in patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), and its correlation with vitamin D level.

Materials And Methods: Serum and urine samples were collected from 50 patients with RA and SLE. DNA was extracted and subjected to PCR test. Positive PCR products were sequenced, phylogenetic tree was constructed to determine the JC virus genotype. The patient's vitamin D level was evaluated.

Results: Of 50 patients, 19 (38%) were diagnosed as RA, and 31 (62%) were identified as SLE. JC virus DNA was detected in 17 (34%) patients' urine samples including 5 (26.3%) RA and 12 (38.7%) SLE cases. JC virus DNA was detected 2 (4%) in patients' serum samples (one RA. and one SLE). JC virus genotype 3A was dominant. Interestingly, the SLE patients with positive JC virus showed lowered vitamin D compared to patients with negative JC virus (P<0.005).

Conclusion: Given the high rate of JC virus, DNA detection and susceptibility of patients for PML development, it is recommended that detection of JC virus DNA and vitamin D level should be implemented for patients with RA/SLE prior to treatment.

References

Comar M, Delbue S, Lepore L, Martelossi S, Radillo O, Ronfani L . Latent viral infections in young patients with inflammatory diseases treated with biological agents: prevalence of JC virus genotype 2. J Med Virol. 2013; 85(4):716-22. DOI: 10.1002/jmv.23525. View

Goncalves-Mendes N, Talvas J, Duale C, Guttmann A, Corbin V, Marceau G . Impact of Vitamin D Supplementation on Influenza Vaccine Response and Immune Functions in Deficient Elderly Persons: A Randomized Placebo-Controlled Trial. Front Immunol. 2019; 10:65. PMC: 6375825. DOI: 10.3389/fimmu.2019.00065. View

Molloy E . PML and rheumatology: the contribution of disease and drugs. Cleve Clin J Med. 2011; 78 Suppl 2:S28-32. DOI: 10.3949/ccjm.78.s2.07. View

Kapoor T, Mahadeshwar P, Hui-Yuen J, Quinnies K, Tatonetti N, Gartshteyn Y . Prevalence of progressive multifocal leukoencephalopathy (PML) in adults and children with systemic lupus erythematosus. Lupus Sci Med. 2020; 7(1). PMC: 7282388. DOI: 10.1136/lupus-2020-000388. View

Schogler A, Muster R, Kieninger E, Casaulta C, Tapparel C, Jung A . Vitamin D represses rhinovirus replication in cystic fibrosis cells by inducing LL-37. Eur Respir J. 2015; 47(2):520-30. DOI: 10.1183/13993003.00665-2015. View

Cinque P, Koralnik I, Gerevini S, Miro J, Price R . Progressive multifocal leukoencephalopathy in HIV-1 infection. Lancet Infect Dis. 2009; 9(10):625-36. PMC: 2919371. DOI: 10.1016/S1473-3099(09)70226-9. View

Mocsai A, Kovacs L, Gergely P . What is the future of targeted therapy in rheumatology: biologics or small molecules?. BMC Med. 2014; 12:43. PMC: 3975154. DOI: 10.1186/1741-7015-12-43. View

Campbell G, Spector S . Vitamin D inhibits human immunodeficiency virus type 1 and Mycobacterium tuberculosis infection in macrophages through the induction of autophagy. PLoS Pathog. 2012; 8(5):e1002689. PMC: 3349755. DOI: 10.1371/journal.ppat.1002689. View

Atyabi S, Bouzari M, Kardi M . John Cunningham (JC) virus genotypes in kidney transplant recipients, rheumatoid arthritis patients and healthy individuals in Isfahan, Iran. J Med Virol. 2016; 89(2):337-344. DOI: 10.1002/jmv.24626. View

10.

Szekanecz Z, McInnes I, Schett G, Szamosi S, Benko S, Szucs G . Autoinflammation and autoimmunity across rheumatic and musculoskeletal diseases. Nat Rev Rheumatol. 2021; 17(10):585-595. DOI: 10.1038/s41584-021-00652-9. View

11.

Agostini H, Deckhut A, Jobes D, Girones R, Schlunck G, Prost M . Genotypes of JC virus in East, Central and Southwest Europe. J Gen Virol. 2001; 82(Pt 5):1221-1331. DOI: 10.1099/0022-1317-82-5-1221. View

12.

Bastian A, Schafer H . Human alpha-defensin 1 (HNP-1) inhibits adenoviral infection in vitro. Regul Pept. 2001; 101(1-3):157-61. DOI: 10.1016/s0167-0115(01)00282-8. View

13.

Loeb M, Dang A, Thiem V, Thanabalan V, Wang B, Nguyen N . Effect of Vitamin D supplementation to reduce respiratory infections in children and adolescents in Vietnam: A randomized controlled trial. Influenza Other Respir Viruses. 2018; 13(2):176-183. PMC: 6379634. DOI: 10.1111/irv.12615. View

14.

Cortese I, Reich D, Nath A . Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease. Nat Rev Neurol. 2020; 17(1):37-51. PMC: 7678594. DOI: 10.1038/s41582-020-00427-y. View

15.

Tanasescu R, Frakich N, Chou I, Filippini P, Podda G, Xin G . Natalizumab Treatment of Relapsing Remitting Multiple Sclerosis Has No Long-Term Effects on the Proportion of Circulating Regulatory T Cells. Neurol Ther. 2023; 12(6):2041-2052. PMC: 10630259. DOI: 10.1007/s40120-023-00539-9. View

16.

Gorelik L, Reid C, Testa M, Brickelmaier M, Bossolasco S, Pazzi A . Progressive multifocal leukoencephalopathy (PML) development is associated with mutations in JC virus capsid protein VP1 that change its receptor specificity. J Infect Dis. 2011; 204(1):103-14. PMC: 3307153. DOI: 10.1093/infdis/jir198. View

17.

Yasin B, Pang M, Turner J, Cho Y, Dinh N, Waring A . Evaluation of the inactivation of infectious Herpes simplex virus by host-defense peptides. Eur J Clin Microbiol Infect Dis. 2000; 19(3):187-94. DOI: 10.1007/s100960050457. View

18.

Connelly K, Morand E . Systemic lupus erythematosus: a clinical update. Intern Med J. 2021; 51(8):1219-1228. DOI: 10.1111/imj.15448. View

19.

Simopoulou T, Tsimourtou V, Katsiari C, Vlychou M, Bogdanos D, Sakkas L . Progressive multifocal leukoencephalopathy in a patient with systemic sclerosis treated with methotrexate: A case report and literature review. J Scleroderma Relat Disord. 2022; 5(3):NP1-NP6. PMC: 8922622. DOI: 10.1177/2397198320926883. View

20.

Makvandi M, Mombeini H, Haghighi S, Dastoorpoor M, Khodadad N, Karimi Babaahmadi M . Molecular epidemiology of JC polyomavirus in HIV-infected patients and healthy individuals from Iran. Braz J Microbiol. 2019; 51(1):37-43. PMC: 7058753. DOI: 10.1007/s42770-019-00117-y. View